Page last updated: 2024-09-03

cgp 42112a and Ovarian Neoplasms

cgp 42112a has been researched along with Ovarian Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bae, DS; Cho, YJ; Choi, CH; Choi, JJ; Do, IG; Jeon, HK; Kim, BG; Kim, TJ; Lee, JK; Lee, JW; Lee, YY; Park, YA; Ryu, JY; Song, SY	1

Other Studies

1 other study(ies) available for cgp 42112a and Ovarian Neoplasms

Article	Year
Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma. Gynecologic oncology, 2014, Volume: 135, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Carcinoma, Ovarian Epithelial; Cells, Cultured; Disease Progression; Drug Therapy, Combination; Female; Humans; Losartan; Middle Aged; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Oligopeptides; Ovarian Neoplasms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2	2014

Article

Year

Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma.

Gynecologic oncology, 2014, Volume: 135, Issue:1

Topics: Angiotensin II Type 1 Receptor Blockers; Carcinoma, Ovarian Epithelial; Cells, Cultured; Disease Progression; Drug Therapy, Combination; Female; Humans; Losartan; Middle Aged; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Oligopeptides; Ovarian Neoplasms; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2

2014